Trending menu:
News
-
16 January 2019
EMA publishes revised guidelines on antibacterial drug development
The European Medicines Agency (EMA) has published revised guidelines on the development and evaluation of human medicines intended to treat bacterial infections.
-
7 January 2019
The Top 10: 2018
Clinical Trials Arena highlights the best articles from 2018
-
12 December 2018
Industry Viewpoints: Choosing the Right CRO
In this Industry Viewpoint, CTA’s Elizabeth Williams speaks with Philip Arlen to discuss key considerations when formulating an outsourcing strategy
-
3 December 2018
The Top 5: November 2018
CTA highlights the best articles from the month of November 2018
-
14 November 2018
The Ongoing Fight Against Diabetes
On World Diabetes Day, CTA’s Harry Parsons delves in to the disease, looking at the impact it has on families
-
14 November 2018
How to Conduct a Diabetes Trial – Lessons Learned
Jacqueline Mardell, Ascendis Pharma, recounts experiences from a multinational type 2 diabetes trial and draws conclusions
-
12 November 2018
Expert Insights: AstraZeneca Makes Strides to Expand its Market and Improve Health Care in China
Edit Kovalcsik, PhD, Managing Analyst, GlobalData, explores AstraZeneca’s plans to enter into the Chinese health care space
-
9 November 2018
Poor Communication Can Cost You – REALLY Cost You
Daria Wicks, Director, Clinical Operations, Vericel Corporation, emphasizes the importance of clear communication within an organization
-
6 November 2018
The Stem Cell Emperor’s New Clothes
James L. Sherley, M.D., Ph.D., Founder and Director, Asymmetrex, exposes a problem in the global stem cell supply industry that is crippling progress in stem cell medicine
-
5 November 2018
Announcing ‘The Return of Outsourcing Week’ on Clinical Trials Arena
Throughout this week, CTA will spotlight the ever-changing outsourcing landscape